Showing posts with label Inc.. Show all posts
Showing posts with label Inc.. Show all posts

Wednesday 2 January 2019

Photonic IC Market Size Poised To Reach USD 3.54 Billion By 2024:Key Participant Ciena Corporation, and Emcore Corporation


San Francisco, 02 January 2019, Photonic Integrated Circuit (IC) Market Analysis By Component (Lasers, MUX/DEMUX, Optical Amplifiers, Modulators, Attenuators, and Detectors), Integration (Monolithic, Hybrid, and Module), Raw Material (Indium Phosphide, Silica-on-Silicon, Silicon, Gallium Arsenide, and Others), Application (Optical Communication, Sensing, Biophotonics, and Optical Signal Processing) And Segment Forecasts To 2024

The photonic IC market is expected to reach USD 3.54 billion by 2024 according to a new report by Grand View Research, Inc. Photonic IC is an integrated circuit that uses optical wavelength as an information signal and provides multiple integrated photonic functions. Photonic IC, as such, is similar to an electronic IC and can be a viable replacement for it as well as for the copper-based wired transmission. Photonic IC forms an integral part of lasers, optical amplifiers, modulators, and MUX/DEMUX components, which are extensively used in the optical signal processing, optical communication, biophotonics, and sensing applications. The growing demand for sensing and optical devices are expected to fuel the growth of the photonic IC market.
There is an increasing need for cost effective, power efficient, and compact PICs which would further propel the photonic IC market over the forecast period across the mobile broadband Internet access, high-performance computing, datacenter, and enterprise networking, along with metro and long haul data communications, among many others. The increasing adoption of the high-level integrated PICs and application-specific PICs would boost the photonic IC market to strive for greater functionality and new product development across a number of verticals.
The photonic IC market is anticipated to grow substantially due to the continuous technological advancements and the evolving end-user demands. The laser, optical amplifier, and MUX/DEMUX component segments possess enormous growing opportunities, owing to the ability of photonic ICs to incorporate new optical functionalities that can be embedded on a single chip to achieve high efficiency and compactness.
The increasing demand for the optical communication and sensing applications is driving the growth of photonic ICs around the globe with an efficient management of datacenters and long haul networks providing a thriving market for them. Moreover, with the advancements in quantum computing, the adoption of photonic ICs are increasing as they allow multitasking that quantum computing readily requires. Also, the growing adoption of the biophotonic application in medical devices also holds considerable growth opportunities for the photonic ICs market. On the other hand, the high bandwidth and optimum performance requirements of the telecommunication industry, data storage, cloud service providers, and large business enterprises are expected to boost the optical communication and signal processing segments. This market will create many new opportunities culminating in an increased adoption of photonic ICs over the forecasted period.
Access Full Research Report On Photonic Integrated Circuit (IC) Market Analysis:www.grandviewresearch.com/industry-analysis/photonic-integrated-circuit-ic-market
Further key findings from the report suggest:
·         There is a growing need for higher bandwidth and greater transmission speeds across the Information and Technology (IT) industry. Photonic ICs can be incorporated into the existing products to fulfill this demand in diverse industry verticals to transmit, receive, and switch high-speed digital signals in communication networks. Progressive research and developments are being made towards the low-cost, high-performance optics to help lower the cost of the high-speed Internet access and boost the efficiency of the telecommunication networks
·         The growing shift towards quantum computing and machine learning, among others, requires enormous parallel computing capabilities. The optical quantum computers can perform much faster than the traditional computers in terms of multitasking, higher level of integration, and efficiency while consuming lower power. This will open new avenues for photonic IC-based computing services across a wide range of verticals.
·         Broadcom Limited (U.S.), Viavi Solutions, Inc. (U.S.), and NeoPhotonics Corporation (U.S.) are some of the major industry players in this domain. Other key vendors include Oclaro, Inc., Kaiam Corp, Luxtera Inc., Infinera Corp., Finisar Corporation, Ciena Corporation, and Emcore Corporation, among others.
Grand View Research has segmented the global photonic integrated circuit (IC) market on the basis of product, application and region:
Photonic IC Market Component Outlook (Revenue, USD Million, 2014 - 2024)
·         Lasers
·         MUX/DEMUX
·         Optical Amplifiers
·         Modulators
·         Attenuators
·         Detectors
Photonic IC Market Raw Material Outlook (Revenue, USD Million, 2014 - 2024)
·         Indium Phosphide (InP)
·         Gallium Arsenide (GaAs)
·         Lithium Niobate (LiNbO3)
·         Silicon
·         Silica-on-Silicon
Photonic IC Market Integration Outlook (Revenue, USD Million, 2014 - 2024)
·         Monolithic Integration
·         Hybrid Integration
·         Module Integration
Photonic IC Market Application Outlook (Revenue, USD Million, 2014 - 2024)
·         Optical Communication
·         Sensing
·         Biophotonics
·         Optical Signal Processing
Photonic IC Market Regional Outlook (Revenue, USD Million, 2014 - 2024)
·         North America
·         Europe
·         Asia Pacific
·         RoW


Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Tuesday 1 January 2019

Infectious Disease Therapeutics Market Likely To Reach A Valuation Of Around USD 86.2 Billion By 2025:Key Participant Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd.


San Francisco, 31 December 2018,  Infectious Disease Therapeutics Market Analysis By Disease Type (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis, and HPV infection), By Region, And Segment Forecasts, 2018 – 2025.
The global top6 infectious disease therapeutics market is expected to reach USD 86.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.
Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.
In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.
North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.
Access Full Research Report On Infectious Disease Therapeutics Market Analysis:www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market

Further Key Findings From the Report Suggest:
·         The HIV therapeutics segment held the largest revenue share in 2016 due to high number of HIV cases globally
·         North America dominated the global market owing to the strong reimbursement framework coupled with high adoption rate of treatments for infectious diseases
·         The HPV therapeutics segment is estimated to grow at the highest rate during the forecast period
·         Some of the key players areNovartis AG, Gilead, GlaxoSmithKline plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the top 6 infectious disease therapeutics market on the basis of disease type and region:
Disease Type Outlook (Revenue, USD Million, 2014 - 2025)
·         HIV
o    Emtriva
o    Aptivus
o    Isentress
o    Lexiva/Telzir
o    Selzentry
o    Tivicay 
o    Atripla
o    Complera
o    Genvoya
o    Odefsey
o    Stribild
o    Truvada
o    Triumeq
o    Descovy
o    Vitekta
o    Others
·         Influenza
o    Relenza
o    Tamiflu 
o    Rapivab 
o    Others
·         TB
o    Sirturo
o    Others
·         Malaria
o    Coartem
o    Others
·         HPV
·         Hepatitis
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/



Sunday 30 December 2018

Pediatric Vacciness Market Likely To Reach A Valuation Of Around USD 60.4 Billion By 2025:Key Participant GlaxoSmithKline plc, Pfizer, Inc.


San Francisco, 31 December 2018,  Pediatric Vaccines Market Analysis By Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Subunit, Toxoid, Conjugate), By Application (Infectious Diseases, Cancer, Allergy), By Region, And Segment Forecasts, 2018 – 2025
The global pediatric vaccines market is expected to reach USD 60.4 billion by 2025 at an 11.7% CAGR, according to a new report by Grand View Research, Inc. Advancements in development of vaccines and new product launches are some of the major drivers of the market. 
Increase in investments by companies to capture a larger market share is anticipated to propel growth. Some of the factors attributed to increase in investment are high growth prospects in the emerging market, immunization schedule mandated by doctors for children, and awareness programs led by UNICEF, WHO, and other healthcare organizations. Furthermore, increase in number of government initiatives for raising awareness about immunization is expected to boost the market for pediatric vaccines.
Advancements in development of novel adjuvants and therapeutic vaccines are expected to drive growth during the forecast period. Ongoing research in novel molecules targeted at specific mechanisms of action in the body is aimed at providing immunity against fatal diseases such as cancer and Zika virus disease. For instance, in June 2016, Inovio Pharmaceuticals, Inc. announced the initiation of phase I clinical trial for their Zika DNA vaccine named GLS-5700.
Access Full Research Report On Pediatric Vaccines Market  Analysis:
www.grandviewresearch.com/industry-analysis/pediatric-vaccine-market
Further key findings from the report suggest:
·         The global pediatric vaccines market was estimated at USD 22.4 billion in 2016 and is expected to grow with a CAGR of 11.7% from 2017 to 2025
·         By type, monovalent emerged as the largest segment due to factors such as high usage and increase in initiatives for R&D activities supported by various governments
·         Conjugate vaccines formed the dominant technology segment in terms of revenue in 2016. Higher adoption of these vaccines and increase in prevalence of infectious diseases contribute to its lead in the market for pediatric vaccines
·         By application, the cancer segment is expected to witness the fastest growth with a CAGR of 12.6% owing to increasing prevalence of cancer and rising need for immunization against the disease
·         North America held the largest revenue share in 2016. Its dominance in the market for pediatric vaccines is owing to factors such as local presence of major players in the industry and extensive R&D activities
·         The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increase in prevalence of infectious diseases and a large target population
·         Key players such as GlaxoSmithKline plc; Pfizer, Inc.; SANOFI; and AstraZeneca dominated the global market for pediatric vaccines in 2016.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global pediatric vaccines market on the basis of type, technology, application, and region:
Type Outlook (Market Revenue in USD Billion, 2014 - 2025)
·         Monovalent
·         Multivalent
Technology Outlook (Market Revenue in USD Billion, 2014 - 2025)
·         Live Attenuated
·         Inactivated
·         Subunit
·         Toxoid
·         Conjugate
·         Others
Application Outlook (Market Revenue in USD Billion, 2014 - 2025)
·         Infectious disease
·         Cancer
·         Allergy
Regional Outlook (Revenue, USD Billion, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    China
o    Japan
o    India
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa

Access Full Press Release of this Report:

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/